{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:15Z","timestamp":1791397395039,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2018R1A2B6001299"],"award-info":[{"award-number":["NRF-2018R1A2B6001299"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2020R1A2C2005690"],"award-info":[{"award-number":["NRF-2020R1A2C2005690"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejmech.2023.115274","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:23:11Z","timestamp":1678414991000},"page":"115274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Antitumor effect of 3-(quinolin-2-ylmethylene)-4,6-dimethyl-5-hydroxy-7-azaoxindole down-regulating the Gas6-Axl axis"],"prefix":"10.1016","volume":"251","author":[{"given":"Dawon","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hui","family":"Been","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajita","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euijung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-gyu","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-6638","authenticated-orcid":false,"given":"Byeong-Seon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115274_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111842","article-title":"Oxindole and its derivatives: a review on recent progress in biological activities","volume":"141","author":"Khetmalis","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115274_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1517\/13543776.2016.1118059","article-title":"2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014)","volume":"26","author":"Leoni","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115274_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/138955712798995039","article-title":"Indolinones as promising scaffold as kinase inhibitors: a review","volume":"12","author":"Prakash","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115274_bib4","first-page":"99","article-title":"SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types","volume":"59","author":"Fong","year":"1999","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.ejmech.2023.115274_bib5","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/jm980123i","article-title":"Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases","volume":"41","author":"Sun","year":"1998","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115274_bib6","first-page":"29","article-title":"Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent","volume":"15","author":"Mendel","year":"2000","journal-title":"Anti Cancer Drug Des."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115274_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/jm0204183","volume":"46","author":"Sun","year":"2003","journal-title":"J. Med. Chem."},{"issue":"43","key":"10.1016\/j.ejmech.2023.115274_bib8","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1039\/C4OB01221F","article-title":"Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities","volume":"12","author":"Lee","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2023.115274_bib9","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1039\/C6OB00406G","article-title":"5-Hydroxy-7-azaindolin-2-one, a novel hybrid of pyridinol and sunitinib: design, synthesis and cytotoxicity against cancer cells","volume":"14","author":"Shah","year":"2016","journal-title":"Org. Biomol. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115274_bib10","first-page":"3747","article-title":"Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD\u2122 lenalidomide","volume":"31","author":"Fryer","year":"2011","journal-title":"Anticancer Res."},{"issue":"21","key":"10.1016\/j.ejmech.2023.115274_bib11","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.3390\/cancers13215305","article-title":"TPH1 and 5-HT7 receptor overexpression leading to gemcitabine-resistance requires non-canonical permissive action of EZH2 in pancreatic ductal adenocarcinoma","volume":"13","author":"Chaudhary","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejmech.2023.115274_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/cncr.25483","article-title":"Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma","volume":"117","author":"Song","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115274_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-018-0769-1","article-title":"Targeting Gas6\/TAM in cancer cells and tumor microenvironment","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.ejmech.2023.115274_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115274_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03385","article-title":"Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities","volume":"3","author":"Lew","year":"2014","journal-title":"Elife"},{"issue":"21","key":"10.1016\/j.ejmech.2023.115274_bib16","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/onc.2015.343","article-title":"Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115274_bib17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1189\/jlb.0909610","article-title":"TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes\/macrophages","volume":"87","author":"Alciato","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"39","key":"10.1016\/j.ejmech.2023.115274_bib18","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1038\/onc.2009.212","article-title":"Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115274_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1593\/neo.91384","article-title":"GAS6\/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche","volume":"12","author":"Shiozawa","year":"2010","journal-title":"Neoplasia"},{"issue":"47","key":"10.1016\/j.ejmech.2023.115274_bib20","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/onc.2013.487","article-title":"Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy","volume":"33","author":"Leconet","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115274_bib21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevOncog.2019031641","article-title":"Gemcitabine: a review of chemoresistance in pancreatic cancer","volume":"24","author":"Sarvepalli","year":"2019","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.ejmech.2023.115274_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1476-4598-8-125","article-title":"Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines","volume":"8","author":"Huanwen","year":"2009","journal-title":"Mol. Cancer"},{"issue":"22","key":"10.1016\/j.ejmech.2023.115274_bib23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1038\/sj.onc.1201123","article-title":"Intracellular signaling of the Ufo\/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site","volume":"14","author":"Braunger","year":"1997","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115274_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.113","article-title":"Molecular insights of Gas6\/TAM in cancer development and therapy","volume":"8","author":"Wu","year":"2017","journal-title":"Cell Death Dis."},{"issue":"29","key":"10.1016\/j.ejmech.2023.115274_bib25","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1038\/sj.onc.1202788","article-title":"Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras","volume":"18","author":"Goruppi","year":"1999","journal-title":"Oncogene"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:38Z","timestamp":1759330178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"alternative-id":["S0223523423002404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115274","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumor effect of 3-(quinolin-2-ylmethylene)-4,6-dimethyl-5-hydroxy-7-azaoxindole down-regulating the Gas6-Axl axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115274"}}